LONDON, Feb. 4 -- The government of the United Kingdom issued the following news: * Every cancer patient toreceivea tailoredsupport plancovering treatment, mental health, and employment supportunder ... Read More
LONDON, Feb. 4 -- The government of the United Kingdom issued the following news: The Driver and Vehicle Standards Agency (DVSA)hassuccessfully prosecuted 2 men for dangerous MOT fraud. Owain Shaw, ... Read More
LONDON, Feb. 4 -- The government of the United Kingdom issued the following news: Michelle Cracknell Reappointed from 1st January 2026 to 31st December 2028. Michelle was Chief Executive and Accoun... Read More
LONDON, Feb. 4 -- The government of the United Kingdom issued the following news: * UK galvanises global attention on Sudan, the world's greatest humanitarian crisis, and the staggering scale of rape... Read More
LONDON, Feb. 4 -- The government of the United Kingdom issued the following news: The British High Commission (BHC) in Yaounde is inviting proposals from qualified and reputable suppliers for the sup... Read More
LONDON, Feb. 4 -- The government of the United Kingdom issued the following news: * Plans to speed up building ofpioneeringnuclear technology to power AI boom and grow economy with clean energy * Gov... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388537) titled 'Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adult... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388524) titled 'Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prev... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388563) titled 'Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma' on Feb. 4... Read More
Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (NCT07388550) titled 'Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute ... Read More